Kyle McGeehan
Program: Cancer Biology
Current advisor: Alexander Stegh, PhD
Undergraduate university: University of Notre Dame
Research summary
Glioblastoma (GBM) is the most common malignant, primary brain tumor of the central nervous system and remains an incurable disease with a median survival of about 15 months. Despite recent advances in immunotherapy in other types of cancer, no such clinical benefit exists for patients with GBM. My research project is focused on investigating the resulting impact that laser interstitial thermal therapy has on the GBM immune microenvironment in hopes of leveraging laser ablation with immunotherapy for a potential cure.
Graduate publications